Skip to main content
Clinical Trials/NCT07452094
NCT07452094Not yet recruitingPhase 1

Type III/IV Muscle Afferents in Airway and Thermoregulatory Responses

Northern Arizona University1 site in 1 country15 target enrollmentStarted: April 1, 2026Last updated:
Interventions

Trial Snapshot

Phase
Phase 1
Status
Not yet recruiting
Enrollment
15
Locations
1
Primary Endpoint
Airway resistance

Study Overview

Brief Summary

Exercise places serious demands on the body. These demands are fundamentally caused by increases in oxygen demand and the consequent increase in body temperature. These demands are met by several physiological responses, including increases in heart rate, blood pressure, breathing and blood flow. These responses must be proportional to the increase in demand and some signal must relay information from the muscle to the brain. Group III/IV afferents do just this. They relay information about the muscle (movement, temperature, acidity, etc.) up to the brain so that appropriate responses are mounted. There is strong evidence in animals that group III/IV afferents play a key role in making breathing easier (decreasing airway resistance) and initiating sweating and blood flow responses. There has been no research on the role of group III/IV afferents on these fundamental exercise responses in humans. The investigators propose to isolate the role of group III/IV afferents on regulate airway resistance, sweating and blood flow responses to exercise in humans.

Detailed Description

Group III/IV afferents are nerves that relay information from the muscles to the central nervous system. This afferent activity acts as negative feedback to minimize the overall strain placed on muscles . Without this negative feedback, locomotor muscles become damaged during intense exercise. It is well-established that group III/IV afferents are required for normal breathing and blood pressure responses to physical activity. In certain disease states, such as chronic obstructive pulmonary disease, heart failure and hypertension, group III/IV afferents become dysfunctional and lead to exercise intolerance. This is a major issue in these patient groups where regular exercise is advocated to slow or halt disease progression. Understanding how these reflexes contribute to basic cardiorespiratory responses to exercise is thus warranted.

At the onset of exercise, there is a near instantaneous decrease in airway resistance that permits high rates of breathing ; these high rates of breathing are essential to ensure appropriate oxygen transport to working muscles. The decrease in airway resistance is facilitated by a rapid withdrawal of parasympathetic tone to the smooth muscle lining the airways, allowing them to open up and remain rigid. Evidence in cats and dogs indicate that group III/IV afferents reflexively contribute to this response, thereby coupling airway dilation to muscle work. Airway resistance can be quantified by measuring the work required by breathing muscles to pull air into and push air out of the lungs. If the magnitude of airway dilation changes due to the suppression of group III/IV afferents, the investigators would observe a compensatory increase in how much work is required to overcome resistance. This has not been investigated directly in humans.

Alongside the fundamental cardiorespiratory responses to exercise, humans mount powerful thermoregulatory responses that dissipate heat generated from muscle work. The primary thermoregulatory responses in humans are eccrine sweating and skin vasodilation; both of which are activated as body temperature rises. Exercise augments thermoregulatory responses to heating, and sweating is initiated within 1-2 seconds of initiating exercise despite body temperature remaining stable. Thus, there is clearly a link between muscular work and thermoregulation. Reduced preparations in cats have shown that group III/IV afferent activity is elevated during external muscle heating, and human sweating responses are more closely coupled to muscle temperature than to core or skin temperature. To date, no study in humans has tried to isolate the role of group III/IV afferents on thermoregulatory responses to exercise.

These group III/IV afferents can be studied in exercising humans by suppressing their activity using intrathecal (spinal) opioids. Simply, a subject exercises on two different occasions, one with intact muscle reflex feedback, and the other with the feedback suppressed; differences in exercise responses are isolated to the role of group III/IV afferents. The investigators aim to use this model to quantify the contribution of group III/IV afferent reflexes to airway resistance, sweating and skin vasodilation.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Basic Science
Masking
Triple (Participant, Investigator, Outcomes Assessor)

Masking Description

Participant will be blinded to condition. Researcher will be blinded to condition. Researcher will be masked to data during analysis.

Eligibility Criteria

Ages
18 Years to 40 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • regularly physically active as determined via questionnaires (Par-Q & You)
  • maximal aerobic power 30 mL/min/kg (female), 40 mL/kg/min (male)

Exclusion Criteria

  • current smokers
  • acute bronchial asthma
  • diabetics
  • chronic back pain
  • peripheral neuropathy
  • chronic obstructive airway or status asthmaticus
  • obese (body mass index > 30 kg/m2)
  • convulsive disorders
  • requiring daily medications that may affect responses to exercise (e.g. anti-hypertensive, anti-arrhythmogenics, blood thinners)
  • history of drug abuse
  • history of disease/dysfunction that could cause complication with exercise (e.g. cardiovascular, respiratory, neurological, musculoskeletal)
  • irregular or absent menstrual cycle
  • pregnant or suspected pregnancy
  • adverse response to physical exercise
  • current or history of esophageal or gastric disease, or frequent heart burn (>2x per week)
  • Lidocaine allergy

Arms & Interventions

Placebo-control

Placebo Comparator

Exercise with saline injection

Intervention: EXERCISE TRAINING WITH OR WITHOUT MEDICATION (Drug)

Group III/IV afferent blockade

Experimental

Feedback from group III/IV afferents is blocked

Intervention: EXERCISE TRAINING WITH OR WITHOUT MEDICATION (Drug)

Outcomes

Primary Outcomes

Airway resistance

Time Frame: 2 weeks

Calculated based of work of breathing and ventilation flow rate

Sweat rate

Time Frame: 2 weeks

Local eccrine sweat rates at 3 different sites

Skin blood flow

Time Frame: 2 weeks

Skin blood flux measured at different skin sites

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials